A Novel Anticancer Effect of Ephedra alata Decne in Breast Cancer Cells

Area of Science:

• Phytochemistry
• Cancer Biology
• Pharmacology

Background:

• Cancer is characterized by uncontrolled cell growth, necessitating novel therapeutic strategies.
• Natural products are increasingly explored for their potential to induce apoptosis in cancer cells.
• Ephedra alata (E.A.) is a plant source of various secondary metabolites with potential medicinal properties.

Purpose of the Study:

• To investigate the antiproliferative, antimigratory, and apoptosis-inducing effects of an Ephedra alata (E.A.) methanolic extract on breast cancer cells.
• To identify secondary metabolites present in the E.A. extract using LC-MS/MS analysis.
• To evaluate the molecular mechanisms underlying E.A. extract-induced apoptosis.

Main Methods:

• LC-MS/MS analysis was employed to identify secondary metabolites in the E.A. extract.
• Antiproliferative effects were assessed using the crystal violet assay.
• Antimigratory and apoptosis-inducing effects were evaluated through wound healing assays, Annexin V/7 AAD staining, Hoechst staining, ROS production assays, and Western blotting for apoptotic proteins.

Main Results:

• LC-MS/MS analysis identified 20 secondary metabolites in the E.A. extract, including flavonoids, phenolic acids, and proanthocyanidins.
• E.A. extract significantly reduced breast cancer cell viability in a dose- and time-dependent manner.
• E.A. extract inhibited 4T1 cell migration and induced apoptosis, evidenced by increased ROS production and activation of caspases.

Conclusions:

• The methanolic extract of Ephedra alata possesses significant antiproliferative and apoptosis-inducing properties against breast cancer cells.
• E.A. extract demonstrates potential as a natural therapeutic agent for cancer treatment.
• Further research into the specific compounds and mechanisms of E.A. extract is warranted for drug development.